Back | Next |
home / stock / cort / cort message board
Subject | By | Source | When |
---|---|---|---|
It's their only marketed drug and it's main | joev2 | investorshub | 09/22/2018 9:38:20 AM |
Might want to take a deeper look into | Epson | investorshub | 09/22/2018 6:16:49 AM |
can you post detail info , thanks | D E | investorshub | 06/18/2018 7:49:50 PM |
Ugly. Patent being tested in Courts by $TEVA.. | FairviewInvestor | investorshub | 06/18/2018 7:36:26 PM |
took all off on that last $18.00 attempt | FairviewInvestor | investorshub | 04/27/2018 12:57:28 PM |
Article on Corcept here, April 10, 2018 Washington | north40000 | investorshub | 04/11/2018 5:31:37 PM |
breakout territory - 10day chart looking good | FairviewInvestor | investorshub | 03/19/2018 9:27:56 PM |
Nice move last week or so. Back | FairviewInvestor | investorshub | 03/15/2018 5:50:48 PM |
Great Move, Great Chart | FairviewInvestor | investorshub | 01/30/2018 12:49:31 AM |
My new Home of future Profits | FairviewInvestor | investorshub | 12/22/2017 3:42:04 PM |
$CORT's pipeline is valued at zero. | FairviewInvestor | investorshub | 12/22/2017 7:31:18 AM |
missed that Pop, but bought back at open | FairviewInvestor | investorshub | 12/22/2017 7:30:47 AM |
and OUT $15.65 that big candle dip to | FairviewInvestor | investorshub | 12/19/2017 8:29:46 PM |
Starter $15.82 | FairviewInvestor | investorshub | 12/19/2017 7:53:03 PM |
See Acad-Pharm.com for PR re phase 2 CTAD | north40000 | investorshub | 11/05/2017 2:39:12 AM |
http://alanhobbes.blogspot.co.uk/2017/05/corcept-therapeutics-cort-q1-2017.html? | Thurly | investorshub | 06/29/2017 2:33:25 PM |
When should we look for new test results | joe went fishing | investorshub | 06/27/2017 6:07:28 PM |
Another board for $CORT: | north40000 | investorshub | 06/03/2017 2:51:34 AM |
New to $CORT. Looking for thoughts as | joe went fishing | investorshub | 06/03/2017 1:29:51 AM |
$CORT: One of four---- | north40000 | investorshub | 05/23/2017 5:26:09 AM |
News, Short Squeeze, Breakout and More Instantly...
Corcept Therapeutics Incorporated Company Name:
CORT Stock Symbol:
NASDAQ Market:
2024-05-02 17:30:02 ET Truist Financial analyst issues BUY recommendation for CORT on May 2, 2024 04:01PM ET. The previous analyst recommendation was Buy. CORT was trading at $25.06 at issue of the analyst recommendation. The overall analyst consensus : BUY. Current ...
Enact Holdings Inc. (ACT) is expected to report $0.99 for Q1 2024 FormFactor Inc. (FORM) is expected to report $0.09 for Q1 2024 SAAB AB - Class B (SAABF) is expected to report for quarter end 2024-03-31 Lumos Pharma Inc. (LUMO) is expected to report $-1.21 for Q1 2024 Axis Capita...
MENLO PARK, Calif., April 29, 2024 (GLOBE NEWSWIRE) -- Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of th...